Tomer M Mark (Tomer Mark)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Multiple Myeloma

Chronic Lymphocytic Leukemia

Top Venues

American journal of hematology

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Pieter Sonneveld, Asher Chanan-Khan, Katja Weisel, Ajay K Nooka, Tamas Masszi, Meral Beksac, Ivan Spicka, Vania Tietsche de Moraes Hungria, Markus Munder, Maria-Victoria Mateos-Manteca, Tomer M Mark, Mark-David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Peter A Forsberg, Adriana C Rossi, Angelique Boyer, Roger N Pearse, Karen A Pekle, David Jayabalan, Stephanie Lakritz, Kari Flicker, Drew Ribadeneyra, Brielle Liotta, Scott Ely, Leora Boussi, John N Allan, Morton Coleman, Ruben Niesvizky, Tomer M Mark
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. American journal of hematology 96 (12) (2021)
Tomer M Mark, Angelica Falkenstein, Jonathan K Kish
Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma. Future oncology (London, England) (2021)
Peter A Forsberg, Adriana C Rossi, Angelique Boyer, Linda Tegnestam, Roger N Pearse, Arthur Perry, Karen A Pekle, David Jayabalan, Scott Ely, Leora Boussi, Daniel W Sherbenou, Colt Williams, John N Allan, Morton Coleman, Ruben Niesvizky, Tomer M Mark
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. American journal of hematology 94 (5) (2019)